Argenx Expands Partnership With Fujifilm Biotechnologies to Support Local-for-Local Medicine Supply

MT Newswires Live

Sep 18

Argenx (ARGX) is expanding its partnership with Fujifilm Biotechnologies to support local-for-local supply of medicines in the US, Fujifilm said Thursday.

The company said argenx will benefit from its network that provides local-for-local supply, manufacturing close to its patients.

Fujifilm said argenx is the first announced tenant at phase II expansion at its North Carolina site, where it will start manufacturing argenx's drug substance for efgartigimod in 2028.

Efgartigimod is approved worldwide for the treatment of adults with generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, which are chronic autoimmune neuromuscular diseases, Fujifilm said.

Price: 733.52, Change: -0.83, Percent Change: -0.11

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2568872403"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2568872403\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2568872403?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-18 21:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2568872403","market":"hk","top_or_hot":-1,"title":"Argenx Expands Partnership With Fujifilm Biotechnologies to Support Local-for-Local Medicine Supply","media":"MT Newswires Live","content":"<html><body><p> Argenx (ARGX) is expanding its partnership with Fujifilm Biotechnologies to support local-for-local supply of medicines in the US, Fujifilm said Thursday.</p><p>The company said argenx will benefit from its network that provides local-for-local supply, manufacturing close to its patients.</p><p>Fujifilm said argenx is the first announced tenant at phase II expansion at its North Carolina site, where it will start manufacturing argenx's drug substance for efgartigimod in 2028.</p><p>Efgartigimod is approved worldwide for the treatment of adults with generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, which are chronic autoimmune neuromuscular diseases, Fujifilm said.</p><p>Price: 733.52, Change: -0.83, Percent Change: -0.11</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Argenx Expands Partnership With Fujifilm Biotechnologies to Support Local-for-Local Medicine Supply</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArgenx Expands Partnership With Fujifilm Biotechnologies to Support Local-for-Local Medicine Supply\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-18 21:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Argenx (ARGX) is expanding its partnership with Fujifilm Biotechnologies to support local-for-local supply of medicines in the US, Fujifilm said Thursday.</p><p>The company said argenx will benefit from its network that provides local-for-local supply, manufacturing close to its patients.</p><p>Fujifilm said argenx is the first announced tenant at phase II expansion at its North Carolina site, where it will start manufacturing argenx's drug substance for efgartigimod in 2028.</p><p>Efgartigimod is approved worldwide for the treatment of adults with generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, which are chronic autoimmune neuromuscular diseases, Fujifilm said.</p><p>Price: 733.52, Change: -0.83, Percent Change: -0.11</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARGX","symbol_name":"Argenx SE","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2568872403","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2568872403","pubTimestamp":1758203645,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Argenx  is expanding its partnership with Fujifilm Biotechnologies to support local-for-local supply of medicines in the US, Fujifilm said Thursday.The company said argenx will benefit from its network that provides local-for-local supply, manufacturing close to its patients.Fujifilm said argenx is the first announced tenant at phase II expansion at its North Carolina site, where it will start manufacturing argenx's drug substance for efgartigimod in 2028.Efgartigimod is approved worldwide for the treatment of adults with generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, which are chronic autoimmune neuromuscular diseases, Fujifilm said.Price: 733.52, Change: -0.83, Percent Change: -0.11","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARGX":"Argenx SE","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK4139":"生物科技","BK4505":"高瓴资本持仓","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","BK4585":"ETF&股票定投概念","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4588":"碎股","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC"},"translate_title":"Argenx扩大与Fujifilm Biotechnologies的合作伙伴关系，支持本地对本地药品供应","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARGX":1},"content_text":"Argenx (ARGX) is expanding its partnership with Fujifilm Biotechnologies to support local-for-local supply of medicines in the US, Fujifilm said Thursday.The company said argenx will benefit from its network that provides local-for-local supply, manufacturing close to its patients.Fujifilm said argenx is the first announced tenant at phase II expansion at its North Carolina site, where it will start manufacturing argenx's drug substance for efgartigimod in 2028.Efgartigimod is approved worldwide for the treatment of adults with generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, which are chronic autoimmune neuromuscular diseases, Fujifilm said.Price: 733.52, Change: -0.83, Percent Change: -0.11","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}